The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 406.00
Bid: 401.00
Ask: 412.50
Change: -8.00 (-1.93%)
Spread: 11.50 (2.868%)
Open: 407.00
High: 409.50
Low: 406.00
Prev. Close: 414.00
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stress Test Results

28 Jul 2023 17:35

RNS Number : 6282H
Banco Santander S.A.
28 July 2023
 

Banco Santander, S.A. ("Banco Santander"), in compliance with the Securities Market legislation, hereby reports the following:

OTHER RELEVANT INFORMATION

 

Banco Santander reports the results it has obtained in the most recent stress test exercise carried out by the European Banking Authority (EBA) and the European Central Bank (ECB).

The exercise covered a three-year period (end of 2022 - end of 2025) with two scenarios (baseline and adverse) applied to the consolidated perimeter of Santander Group. The CET1 ratio is a financial solvency ratio, the implementation of which is being carried out progressively by financial institutions pursuant to the transitional implementation schedules of the Capital Requirements Directive and Regulation and the International Financial Reporting Standard (IFRS) 9. During the phase-in period of these regulations, in addition to the CET1 Phased-in ratio (a capital ratio calculated pursuant to the transitional regime), which is the legally applicable ratio, the CET1 Fully Loaded ratio (a capital ratio calculated assuming a full implementation of the aforementioned regulations) is also used for information purposes.

The stress test exercise results in the following projected capital ratios for Santander Group for the periods and scenarios considered. A comparison of these projected ratios with the CET1 Fully Loaded ratio (12.04%) and the CET1 Phased-in ratio (12.18%) as of 31 December 2022 is also included in brackets:

 

ADVERSE SCENARIO

BASELINE SCENARIO

 

CET1 Fully Loaded

CET1 Phased- in

CET1 Fully Loaded

CET1 Phased- in

31/12/2023

10.53% (-1.50%)

10.96% (-1.22%)

13.39% (+1.35%)

13.39% (+1.21%)

31/12/2024

10.94% (-1.10%)

11.34% (-0.84%)

14.34% (+2.30%)

14.34% (+2.16%)

31/12/2025

10.33% (-1.70%)

10.33% (-1.84%)

14.44% (+2.40%)

14.44% (+2.26%)

 

Boadilla del Monte (Madrid), 28 July, 2023

 

 

IMPORTANT INFORMATION

Not a securities offer

This document and the information it contains does not constitute an offer to sell nor the solicitation of an offer to buy any securities.

Past performance does not indicate future outcomes

Statements about historical performance or growth rates must not be construed as suggesting that future performance, share price or results (including earnings per share) will necessarily be the same or higher than in a previous period. Nothing in this document should be taken as a profit and loss forecast.

Third Party Information

In this document, Santander relies on and refers to certain information and statistics obtained from publicly-available information and third-party sources, which it believes to be reliable. Neither Santander nor its directors, officers and employees have independently verified the accuracy or completeness of any such publicly-available and third-party information, make any representation or warranty as to the quality, fitness for a particular purpose, non-infringement, accuracy or completeness of such information or undertake any obligation to update such information after the date of this document. In no event shall Santander be liable for any use by any party of, for any decision made or action taken by any party in reliance upon, or for inaccuracies or errors in, or omission from, such publicly-available and third-party information contained herein. Any sources of publicly-available information and third-party information referred or contained herein retain all rights with respect to such information and use of such information herein shall not be deemed to grant a license to any third party.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKXPADFDEFA
Date   Source Headline
3rd May 202311:38 amRNSCovered Bonds: interest rate replacement
28th Apr 202311:39 amRNSTotal Voting Rights
28th Apr 202311:24 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNS1Q2023 Financial report & Earnings presentation
25th Apr 20237:00 amRNS1Q2023 Results - Press release
24th Apr 20237:00 amRNSEnd of the Programme & 19-21 April Transactions
19th Apr 202311:22 amRNSBuyback programme: transactions 12 - 18 April
18th Apr 202311:26 amRNSNotice of First Quarter 2023 Results
12th Apr 202311:04 amRNSBuyback programme: transactions 30 March -11 April
11th Apr 20237:00 amRNSFurther re Santander Mexico tender offer: results
31st Mar 20232:28 pmRNS2023 AGM - Resolutions
31st Mar 202312:11 pmRNSTotal Voting Rights
31st Mar 20237:35 amRNSSantander to confirm its targets for 2023 at AGM
30th Mar 202311:05 amRNSBuyback programme: transactions 23 - 29 March
23rd Mar 202311:40 amRNSDirector/PDMR Shareholding
23rd Mar 202310:22 amRNSBuyback programme: transactions 16 - 22 March
21st Mar 20231:04 pmRNSFurther re capital reduction
17th Mar 202312:21 pmRNSDirector/PDMR Shareholding
16th Mar 20235:16 pmRNSTotal Voting Rights
16th Mar 202311:18 amRNSCapital reduction (buy-back programme shares)
16th Mar 202311:09 amRNSBuyback programme: transactions 9 - 15 March
10th Mar 20239:55 amRNS2022 UK Annual Report
9th Mar 20234:27 pmRNSDirector/PDMR Shareholding
9th Mar 202311:39 amRNSBuyback programme: transactions 1 - 8 March
6th Mar 20233:02 pmRNSDirector/PDMR Shareholding
6th Mar 20232:59 pmRNSDirector/PDMR Shareholding
28th Feb 20235:27 pmRNSNotice of AGM
28th Feb 202312:23 pmRNSTotal Voting Rights
28th Feb 20239:51 amRNSInvestor Day: Group CFO presentation
28th Feb 20238:33 amRNSInvestor Day: Group CEO presentation
28th Feb 20238:05 amRNSInvestor Day: Executive chair presentation
28th Feb 20237:00 amRNSPayout policy, strategic plans & profit forecasts
28th Feb 20237:00 amRNSExecution of 2022 shareholder remuneration policy
24th Feb 20237:00 amRNSDirector/PDMR Shareholding
21st Feb 202310:58 amRNSInvestor Day meeting announcement
17th Feb 20231:33 pmRNSDirector/PDMR Shareholding
7th Feb 202311:24 amRNSTender Offer
2nd Feb 20237:00 amRNS2022 Financial report & Earnings presentation
2nd Feb 20237:00 amRNS2022 Results - Press release
1st Feb 202311:06 amRNSEnd of the Programme & 26 -31 Jan Transactions
31st Jan 20233:22 pmRNSTotal Voting Rights
26th Jan 202311:08 amRNSNotice of 2022 Results
26th Jan 202311:03 amRNSBuyback programme: transactions 19 - 25 January
19th Jan 202311:14 amRNSBuyback programme: transactions 12 - 18 January
12th Jan 202311:29 amRNSBuyback programme: transactions 5 - 11 January
5th Jan 202311:14 amRNSBuyback programme: transactions 29 Dec- 4 Jan
30th Dec 202212:18 pmRNSTotal Voting Rights
29th Dec 202211:06 amRNSBuyback programme: transactions 21- 28 December
28th Dec 20227:00 amRNSTotal Voting Rights
28th Dec 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.